OTCMKTS:MMEDF Mind Medicine (MindMed) (MMEDF) Stock Price, News & Analysis → I tried to warn you (From Porter & Company) (Ad) Free MMEDF Stock Alerts $7.74 -0.27 (-3.37%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$7.70▼$8.1350-Day Range$7.22▼$11.0052-Week Range$0.29▼$5.07Volume617,796 shsAverage Volume3.38 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Ad The Oxford ClubClaim Your FREE "AI Income Playbook" Now!Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Playbook" - and it's yours FREE!Click here now to claim your FREE copy of Marc's AI playbook. About Mind Medicine (MindMed) Stock (OTCMKTS:MMEDF)Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.Read More MMEDF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MMEDF Stock News HeadlinesApril 17, 2024 | finance.yahoo.comMind Medicine (MindMed) Inc. (MNMD)March 27, 2024 | msn.comMind Medicine (NASDAQ:MNMD) is Leading the Surge in Psychedelic TherapiesMarch 22, 2024 | morningstar.comMind Medicine Inc Ordinary SharesMarch 17, 2024 | morningstar.comMind Medicine Inc Ordinary Shares MMEDFebruary 22, 2024 | benzinga.comMind Medicine Stock (NASDAQ:MNMD) Dividends: History, Yield and DatesDecember 20, 2023 | seekingalpha.comMMDCF Mind Medicine (MindMed) Inc. WT EXP 010724December 20, 2023 | msn.comWhat Makes Mind Medicine (MindMed) Inc. (MNMD) a New Buy StockDecember 12, 2023 | finance.yahoo.comMind Medicine (MindMed) Inc. (MMCWF)October 26, 2023 | financialpost.comMindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business UpdateAugust 15, 2023 | benzinga.comMindMed Inks $50M Credit Facility Deal With K2 HealthVentures For An Additional Operational YearAugust 4, 2023 | msn.comRBC Capital Maintains Mind Medicine (MNMD) Outperform RecommendationJuly 19, 2023 | stockhouse.comThinking about buying stock in Mind Medicine (MindMed), OPKO Health, Grange Resources, Hyzon Motors, or Bright Minds Biosciences?July 4, 2023 | thestreet.comMind Medicine (MindMed), Inc.June 27, 2023 | msn.comMindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path UpheldJune 22, 2023 | marketwatch.com8-K: Mind Medicine (MindMed) Inc.May 25, 2023 | businesswire.comMindMed Releases Investor Presentation Highlighting How the Company is Unlocking the Power of Psychedelics for Patients and ShareholdersMay 5, 2023 | benzinga.comFCM Releases Letter to Fellow MindMed Shareholders Highlighting Board and Management's Track Record of Shareholder Value DestructionMay 1, 2023 | benzinga.comMindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business UpdateApril 26, 2023 | msn.comMindMed CEO On Latest Positive Topline Phase 2 Data And Freedom Capital ManagementNovember 11, 2022 | benzinga.comMindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 TrialsOctober 26, 2022 | msn.comMind Medicine (MNMD) to Report Q3 Earnings: What's in Store?October 4, 2022 | nasdaq.comWhy Mind Medicine Stock Triumphed on TuesdaySeptember 29, 2022 | nasdaq.comWhy Mind Medicine Stock Soared on a Down Day for the MarketSeptember 29, 2022 | uk.investing.comMind Medicine Inc (MNMD)September 28, 2022 | nasdaq.comMind Medicine Stock (NASDAQ:MNMD): Investors Just Got a Dose of RealitySee More Headlines Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:MMEDF CUSIPN/A CIKN/A Webwww.mindmed.co PhoneN/AFaxN/AEmployees22Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesMr. Jamon Alexander RahnCo-Founder, CEO & DirectorDr. Miriam Halperin WernliExec. Pres & DirectorDr. Scott M. Freeman (Age 64)Co-Founder & Clinical Advisor Mr. Leonard LatchmanCo-founderMr. David Dean GuebertChief Financial OfficerMs. Carol NastChief Operating OfficerMr. Bradford CrossChief Technology OfficerDr. Donald R. Gehlert Ph.D.Chief Scientific Officer & Member of Scientific Advisory BoardMs. Madeline FeldmanDirector of Operations & Admin.Mr. Collin GageVP of Corp. Devel.More ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors MMEDF Stock Analysis - Frequently Asked Questions How have MMEDF shares performed in 2024? Mind Medicine (MindMed)'s stock was trading at $3.66 at the start of the year. Since then, MMEDF stock has increased by 111.5% and is now trading at $7.74. View the best growth stocks for 2024 here. How do I buy shares of Mind Medicine (MindMed)? Shares of MMEDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MMEDF) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBUY ALERT: Tiny tech play partners with US governmentThe Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. ...Stansberry Research | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Mind Medicine (MindMed) Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.